Professional Documents
Culture Documents
To
The “future” child’s physician
COMPILED BY:
www.DNBpedia.com
AN ACADEMIC PLATFORM FOR DNB PEDIATRICS RESIDENTS
Follow us at: Facebook.com/DNBpedia
2nd Edition
January 2021
FREE TO READ
FREE TO SHARE
Write to us at thechildsphysician@gmail.com
Follow us on Facebook.com/TheChildsPhysician
2
DNBpedia ® 2021
FOREWORD
What’s DNBpedia?
It’s a free eBook containing questions from past 27 years (1993 to 2020) of DNB theory
exams, sorted and indexed according to Nelson Textbook of Pediatrics 21e.
Why use it?
A major chunk of questions in DNB theory are repeated every year. (To be more precise
82% in 2020 June and 70% in 2019 December were from topics asked earlier). When you
master those questions, you feel confident to face exam and you can spend rest of your
time pondering into new questions.
How to use it?
Use it as eBook with clickable hyperlink and index for easy navigation or print it and use
as conventional book. DNBpedia is indexed according to Nelson 21e, previous questions
are grouped chapter wise. Questions in the last 5 year exams are highlighted in red (so
that you get to know the trend in recent exams). Each question is followed by a Numbers
in bracket= Year, 1 = June session, 2= December session and Number outside bracket =
Marks. Egs: (2017/1) 4 means, 2017 June session question with 4 marks.
Once again thank you for using DNBpedia. We pray that it’ll be useful to you. We
admit there may be humanly errors or omissions. We’d grateful if you’d point out if any.
3
DNBpedia ® 2021
CONTENTS
FOREWORD .......................................................................................................3
PART I - FIELD OF PEDIATRICS...........................................................................6
PART II - GROWTH, DEVELOPMENT AND BEHAVIOR .......................................8
PART III - BEHAVIORAL AND PSYCHIATRIC DISORDERS ..................................11
PART IV - LEARNING AND DEVELOPMENTAL DISORDERS ..............................12
PART V - NUTRITION .......................................................................................13
PART VI - FLUID AND ELECTROLYTE DISORDERS ............................................17
PART VII - PEDIATRIC DRUG THERAPY ............................................................19
PART VIII - EMERGENCY MEDICINE AND CRITICAL CARE ...............................20
PART IX - HUMAN GENETICS ..........................................................................23
PART X - METABOLIC DISORDERS ...................................................................25
PART XI - THE FETUS AND THE NEONATAL INFANT........................................26
PART XII - ADOLESCENT MEDICINE .................................................................34
PART XIII - IMMUNOLOGY ..............................................................................35
PART XIV - ALLERGIC DISORDERS....................................................................37
PART XV - RHEUMATIC DISEASES OF CHILDHOOD .........................................39
PART XVI - INFECTIOUS DISEASES ...................................................................41
PART XVII - THE DIGESTIVE SYSTEM ...............................................................50
PART XVIII - THE RESPIRATORY SYSTEM .........................................................56
PART XIX - THE CARDIOVASCULAR SYSTEM ....................................................59
PART XX - DISEASES OF THE BLOOD ...............................................................63
PART XXI - CANCER AND BENIGN TUMORS ....................................................68
PART XXII - NEPHROLOGY ...............................................................................70
PART XXIV - GYNECOLOGIC PROBLEMS OF CHILDHOOD ...............................75
4
DNBpedia ® 2021
5
DNBpedia ® 2021
7
DNBpedia ® 2021
FAILURE TO THRIVE
1. Approach to a child with Failure to Thrive (1996/1)14
2. Causes of Failure to Thrive in infancy (1996/2)15
3. Define failure to thrive. Outline a diagnostic approach for a child with failure to thrive (2004/2)2+8
4. Non organic failure to thrive (2007/1)10
5. Define failure to thrive. Give its aetiology, classification, clinical features and management.
(2009/2) 1+2+2+2+3
6. Define failure to thrive and tabulate its causes. Outline the approach to manage a child with failure
to thrive. (2010/2) 2+3+5
7. Failure to thrive (2015/1) 6
8. Definition and causes of Failure to Thrive (2017/2) 6
9. Causes of FTT and schematic evaluation of FTT (2016/2) 5
SHORT STATURE:
1. Define Short Stature. Discuss the approach to a child with short stature and the role of GH in Short
Stature (2005) 2+5+3
2. Approach to a child with short stature (2006/1) (2007/2) 10
3. Short stature – definition, differential diagnosis and management approach. (2010/1) 2+3+5
4. Define short stature. Outline the approach to clinical evaluation and management of a child with
short stature. (2013/1) 2+8
5. What is short stature. What are the common causes of short stature? Algorithmic approach to
manage a 5-year-old child with short stature. 1+3+6(1/2015)
6. A 12-year-old female child presents with short stature and delayed puberty. Enumerate various
possible causes. Approach to diagnosis and their management. 2+8(1/2016)
7. Approach to a child with short stature (2019/1) 5
Chapter 28 Developmental and Behavioral Surveillance and Screening
1. Gessel Developmental schedule (1993/1)15
2. Various physical features that are likely to be associated with specific syndromes of mental
retardation (1995/2)10
3. Preventable and treatable causes of Mental retardation (1996/2)10
4. Enumerate the causes of mental retardation in children. Give an outline of management of a child
with mental retardation. (2010/1)4+6
5. Enumerate the criteria for diagnosis of mental retardation (MR). Classify MR and describe its
evaluation. (2014/1)2+2+6
6. What is developmental screening? Enumerate common developmental screening test. What
issues they identify in a child? (2012/1) 2+4+4
7. What is developmental delay? Describe different tools used for screening of developmental delay.
(2011/2)3+7
8. Define developmental delay and developmental dissociation. Outline the screening and definitive
tests for diagnosis of developmental delay. (2013/1)5+5
9. What is global developmental delay? What are the common causes of global developmental
delay? Discuss the algorithmic approach to evaluate a child with global developmental delay.
(2013/2)2+3+5
10. What is developmental delay? Describe different tools used for screening and for diagnosis of
developmental delay. (2015/2)2+4+4
11. Tools used for developmental screening (2017/1) 5
12. Define and enumerate the causes of Global Developmental Delay (2017/1) 5
9
DNBpedia ® 2021
13. Outline the investigative approach of Global Developmental Delay (2017/1) 5, (2019/1) 5
Chapter 29 Childcare
Chapter 30 Loss, Separation, and Bereavement
Chapter 31 Sleep Medicine
1. Sleep Disorders in children (1999/2)10
2. Obstructive sleep apnea: Diagnosis and management 5 (2001/16)
3. Pathophysiology of Sleep Apnea (2003/1)15
4. Outline the basic principles of sleep hygiene for children and adolescents (2009/1)10 (2012/1) 5+5
5. Principles of sleep hygiene in children (2013/1) 5
6. Evaluation of Obstructive Sleep Apnea (2014/2) 5
7. a) Mention anatomical and functional factors responsible for obstructive sleep apnea in children 5
b) How do you diagnose and treat this condition 2+3 (2015/2)
8. Nightmares and nocturnal emission (2019/2)5
9. Outline the basic principles of sleep hygiene for children and adolescents. (2020/01)5
10
DNBpedia ® 2021
12
DNBpedia ® 2021
PART V - NUTRITION
3. Enumerate functions of vitamin A in human body. Tabulate the WHO classification of vitamin A
deficiency. Outline the treatment schedule for managing Xerophthalmia in children.
(2010/2)2+3+5
4. Describe WHO classification of eye manifestation of vitamin A deficiency. Discuss prevention &
management of Vitamin A deficiency in children (2014/2) 4+6
5. Hypervitaminosis A. 4 (Apr 2016), 3(1/2016)
Chapter 62 Vitamin B Complex Deficiencies and Excess
1. Discuss the etiopathogenesis, clinical features, diagnosis and management of cobalamine
deficiency. (2012/1) 2+3+1+4
2. Pathophysiology of Vitamin B12 and Folate deficiency. (2020/01)5
Chapter 63 Vitamin C (Ascorbic Acid) Deficiency and Excess
1. Scurvy- radiological changes. How are they produced? What is the role of Blood Level of Vitamin C
in the diagnosis (2005)10
2. Diagnosis of Scurvy (2017/2) 4
Chapter 64 Vitamin D Deficiency (Rickets) and Excess
1. Clinical manifestations of Rickets (1993/2)10
2. Vitamin D Resistant Rickets (1996/2)12
3. Renal Rickets (1997/2) 15
4. Functions of vitamin D (1998/2) 10
5. Resistant Rickets 15
6. Outline the metabolism and function of Vitamin D in human body. Describe in detail the
7. Aetiology and pathological changes in rickets (1999/2)25
8. What are the causes of non-nutritional rickets? How will you manage such a child? (2004/2)3+7
9. Classify the various causes of rickets and outline how to differentiate them (2005)5+5
10. Diagnostic approach to a child with resistant rickets (2006)10
11. Resistant Rickets (2006/1)10
12. Discuss calcium and vitamin D metabolism. Outline an approach to a case of Resistant
13. Rickets (2007/1)10
14. Discuss the pathophysiological basis of clinical and radiological manifestations of nutritional
rickets. (2009/1)10
15. Describe vitamin D metabolism. Describe diagnostic approach to a 3-year-old child with
16. rickets who has shown no response to treatment with 6 lakhs I.U. of vitamin D. (2009/2) 4+6
17. Outline the clinical features, radiological changes, diagnosis and treatment of nutritional
18. Vitamin D deficiency rickets. (2010/2) 2+2+2+4
19. Write in brief the role of vitamin D in health and disease in children. Outline the management of
Vitamin D deficiency disorder. (2012/1) 6+4
20. Hypervitaminosis D 4 (Apr 2016), 3 (1/2016)
21. a. Outline the physiology of vitamin D (1/2016)4
b. Diagnosis and treatment of vitamin D Dependent Rickets. 3+3 (1/2016)
22. Treatment and prevention of Vitamin D Deficiency rickets (2017/2) 6
23. Outline the steps involved in synthesis of Vitamin D (2016/2) 5
24. 7-year-old boy comes with deformities suggestive of rickets. What are the possible causes?
Enumerate the investigations for resistant rickets and treatment of hypophosphatemic rickets
(2016/2) 5
25. Physical, metabolic properties and food sources of Vitamin D (2018/2) 5
Causes and treatment of vitamin D resistant rickets [2018/2]4
15
DNBpedia ® 2021
16
DNBpedia ® 2021
17
DNBpedia ® 2021
9. List the causes of metabolic alkalosis. Describe the pathophysiology, clinical features and
treatment. (2008/2)10
10. Classify metabolic acidosis based on anion gap. Mention the various causes of lactic acidosis.
Describe the approach to diagnosis of inborn error of metabolism in an infant. (2008/2)10
11. Classify and enlist the causes of metabolic alkalosis. Outline the treatment modalities. (2010/1)
3+3+4
12. Define anion gap. Enlist causes of increased anion gap acidosis and discuss its management in
brief. (2011/1)2+3+5
13. What is anion gap? Discuss the acid base distribution in metabolic acidosis. Enumerate the causes
of increased anion gap and normal anion gap metabolic acidosis. 1+5+(2+2)(2015/2)
14. Approach to a child with metabolic alkalosis (2017/2) 5
15. Physiology of acid base homeostasis (2017/1) 5
16. Enumerate the causes of metabolic acidosis on the basis of anion gap (2017/1) 4, (2018/2) 5
17. Causes of metabolic acidosis (2019/1) 5
OSMOLALITY
1. Pathophysiology of regulation of Plasma Osmolality (2006)10
2. Discuss etiopathogenesis, clinical manifestations and management of Bartter Syndrome. (2013/2)
3. Define osmolarity. Discuss the mechanism of regulation of plasma osmolarity in the human body.
(2014/2) 2+8
4. How is plasma osmolality calculated? Discuss its determinants. What are the diagnostic criteria of
SIADH? 3+4+3 (Apr 2016)
5. Pathophysiology and regulation of plasma osmolality 5(1/2016)
6. Determinants of plasma osmolality (2017/2) 6
Chapter 69 Maintenance and Replacement Therapy
Chapter 70 Deficit Therapy
1. Why children are more vulnerable to develop dehydration (1996/2)10
2. One-year-old infant with AGE develops Abdominal Distension. Discuss the differential diagnosis
(1997/1) 10
3. Pathogenesis and Management of Hypernatremic Dehydration (1997/2) 15
4. Management of Acute Diarrhea in children (1998/1)15
5. Management of Hypernatremic Dehydration (2002/1)15
6. Hypernatremic Dehydration (2003/1)15
7. Hyponatremic Dehydration (2003/2) 15
8. Steps in management of patient with Hypernatremic Dehydration (2006)10
9. A one year old infant weighing 5.5kg presents with Acute Dysentery and severe dehydration.
Discuss its complete management (2006/1)10
10. A one year old baby weighing 5.5kg comes in severe dehydration. Discuss complete management
(2007/2)10
11. Discuss causes, predisposing factors and pathophysiology of Hypernatremic dehydration in young
children (2007/1)10
12. Describe the pathophysiology of hyponatremic dehydration. Briefly discuss the management of a
child with serum sodium of 110meq/liter presenting with moderate dehydration and seizures
(2008/2) 10
Chapter 71 Fluid and Electrolyte Treatment of Specific Disorders
18
DNBpedia ® 2021
19
DNBpedia ® 2021
20
DNBpedia ® 2021
14. What is the defining criteria of systemic inflammatory response syndrome (SIRS). Name the
mediators involved and their mode of action. 5+5(2015/2)
15. Etiology, pathogenesis, clinical features and management of cardiogenic shock? 2+3+2+3 (2015/2)
16. Etiopathogenesis and management of septic shock (2016/2) 5
17. Early biomarkers of sepsis (2016/2) 5
18. SIRS (Systemic inflammatory Response Syndrome) (2017/1) 5
19. Pathophysiology of hypovolemic shock (2019/1)
20. Management of a child in the emergency room with peripheral circulatory failure (2019/2)5
Chapter 89 Respiratory Distress and Failure
1. Clinical and physiological features necessary to diagnose respiratory failure in children (1994/2)15
2. Pulse Oximetry and its limitations (1998/1)15
3. Briefly discuss the non-invasive estimation of gas exchange in children. (2004)10
4. How will you define acute respiratory failure? Write common causes of acute respiratory failure in
a 2-year-old child. What are the various methods of oxygen therapy in children. (2004/2)3+3+4
5. Enumerate 4 adventitious sounds that can be heard during examination of respiratory system. At
what anatomical level are they produced? In which conditions are they produced. (2006)10
6. Types of Acute Respiratory Failure in children, modes of assisted ventilation and indications for the
same in Children (2006)10
7. What are the criteria used to diagnose Acute Respiratory Distress Syndrome (ARDS). Write in brief
the pathogenesis, clinical features and lab findings of the same. Discuss the treatment and
ventilatory strategies to manage ARDS. (2008/2)10
8. Describe the various pressures which are used or varied during mechanical ventilation. What is
‘Cycling’ and ‘Control’ in mechanical ventilator? Describe the differences in pressure controlled
and volume controlled ventilation. Illustrate with suitable indication use of these forms of
ventilation. (2008/2)10
9. Describe the pathophysiology, etiology and management of acute respiratory distress syndrome.
(2009/2)3+3+4
10. Define ventilation/ perfusion ratio. (2011/1) 2
Outline Va/Q changes in
a. Pneumonia 2
b. Obstructive lung disease 2
c. ARDS 2
d. Pulmonary thromboembolism 2
11. Classify respiratory failure in children. List the modes of assisted ventilation and its indications
(2013/1)10
12. Write short notes: (2014/1)3+4
a) End – Tidal carbon dioxide monitoring
b) Pulse oximetry
13. Utility of Blood gas (ABG) in localising pathology and severity of disease in respiratory problems
(2015/1)5+5
14. Pulse oxymetry 2 (2015/1)
15. What is Rapid sequence intubation (RSI)? Outline the steps involved. Discuss the indications and
advantages of RSI. (2014/2) 2+5+3
16. Define Acute Lung Injury. Discuss the etiopathogenesis and management of a child with Acute
Lung Injury. (2014/1)2+3+5
17. Write short notes on:
21
DNBpedia ® 2021
22
DNBpedia ® 2021
24
DNBpedia ® 2021
25
DNBpedia ® 2021
26
DNBpedia ® 2021
3. Discuss the methods of detection of congenital malformations in the fetus and their prevention
(1995/1)25
4. Antenatal Diagnosis (1998/2)10
5. Methods to diagnose fetal disorder. Fetal medical therapy (2005)5+5
6. List various methods for Fetal diagnosis and assessment along with indications (2006) 5
7. Prenatal Diagnosis and Fetal therapy (2006/1)10
8. What are the methods of diagnosis of fetal disorders? Describe the fetal medical and surgical
therapeutic options for various fetal disorders. (2009/2) 10
9. Antenatal screening for Down syndrome (2013/1) 5
10. Outline the methods of assessing fetal wellbeing with their clinical indications. (2013/2)
11. Describe in detail tests for antepartum and intrapartum monitoring of fetal distress (2006)5
12. Fetal monitoring (2006) 10
13. Discuss the complications in the fetus and newborn of a mother with diabetes during pregnancy.
(2008/1)10
14. Maternal factors affecting fetal growth (2017/2) 4
15. Assessment of fetal wellbeing in pregnancy (2017/2) 6
16. Antenatal screening (2019/2)4
17. Chorionic villi sampling – method, indications and complications (2019/2)2+2+2
Chapter 116 Fetal Intervention and Surgery
1. Prenatal steroid therapy (1999/2)15
2. Treatment and prevention of fetal diseases (2007/1)10
3. Medical management of Fetal Problems (2007/2)10
4. Fetal Therapy (2003/2)15
5. Steroid in neonatal care (2007/1)5
6. Fetal therapy 5(1/2016)
7. Intrauterine fetal therapy (2019/1) 5
Chapter 117 The High-Risk Infant
1. Define ‘High risk infant’. Discuss the long term management of such infants with emphasis on
detection and early intervention of infants with developmental disabilities (1995/1)25
2. Fluid therapy in special situations in neonates (2006/1)10
3. A) What is Developmentally supportive care. 3
B) Components of developmentally supportive care in neonates (2015/2)7
4. Developmentally supportive care in neonates (2015/1) 3
5. Enumerate the criteria of discharge of LBW baby from SCNU (2019/1) 5
6. Components of facility based newborn care (2018/2) 5
7. Triage of sick newborn who is admitted in SCNU (2018/2) 5
8. Non-nutritive sucking and early infant stimulation (2019/2)5
9. Monitoring of IDM (2019/1) 5
IUGR/SGA
1. Factors associated with IUGR (1993/1)10
2. Immune status of SFD babies (1998/1)15
3. List the principles of community care of LBW infants. Define Kangaroo Mother care. Outline its
advantages and disadvantages. (2004/2)4+2+4
4. Outline the handicaps in enteral feeding of LBW newborns. Briefly discuss the feeding strategies
for LBW babies. (2004/2)3+4+4
27
DNBpedia ® 2021
5. Enumerate the etiology of fetal or intrauterine growth retardation (IUGR). Describe the screening
and diagnosis of IUGR. (2011/2) 3+4+3
6. Immediate and late problems due to low birth weight (2013/1)5
7. Feeding of low birth weight babies 5 (2015/1)
8. Interventions to improve neurodevelopmental outcome of LBW infants at 1 year of age.(2017/2) 6
PRETERM
1. Enumerate the socio-demographic factors associate with Low birth weight babies. Discuss the
clinical problems of Preterm babies (1996/1)25
2. Pharmacotherapy in prematurity clinical decisions salient features (2003/1)15
3. Osteopenia of prematurity (2006)10
4. Management of Patent Ductus Arteriosus (PDA) in preterm neonates (2010/1)10
5. Enumerate the factors associated with prematurity and low birth weight. Discuss the potential
pathways by which infection plays a role in premature delivery. (2013/1)4+6
6. Describe the development of the ductus arteriosus. Enumerate the duct dependent lesions in the
newborn and outline their management. (2014/1)3+2+5
7. Physical difference between preterm and IUGR neonates (2017/2) 4
NUTRITION
1. Write short notes on: Trophic feeding (2013/1)5
2. Discuss attributes, complications and monitoring of total parenteral nutrition in a newborn
(2013/1)5
3. Write short notes on: (2014/1)4+3+3
a. Human Milk Fortifiers
b. Vitamin D supplementation in neonates
c. Medium chain triglycerides in neonatal nutrition
4. Minimal enteral nutrition for low birth weight babies (2019/1) 5
5. Nutritional requirements of preterm babies (2019/1) 5
Chapter 118 Transport of the Critically Ill Newborn
1. Discuss the principles of safe and stable transport of a sick newborn. (2013/1)10
2. Issues related to transport of sick newborn (2014/2)5
Chapter 119 Clinical Manifestations of Diseases in the Newborn Period
1. Foetal circulation and changes at birth (2000/1)15
2. Cyanosis in newborn 5 (Apr16)
3. Newborn screening is useful in which conditions and how it can be done (2018/1)6
Chapter 120 Nervous System Disorders
1. Enumerate common peripheral nerve injuries in neonates. Describe their clinical characteristics
and outline the management. (2009/1)2+3+5
BIRTH ASPHYXIA/ HIE
1. HIE (1993/1) (1992/2)15
2. Prognosis of Birth Asphyxia (1993/1)10
3. HIE in newborn (1995/1)10
4. Discuss the etiopathology and management of birth asphyxia (1996/2)25
5. HIE (1997/2)15
6. Clinical and laboratory correlates of neuromotor outcome in Birth asphyxia (1997/1)10
7. Discuss Briefly pathophysiology and recent modalities of management of HIE (1999/2)25
8. Perinatal asphyxia- clinical features and management (2002/1)15
28
DNBpedia ® 2021
9. What are the etiological causes of Fetal Hypoxia? Write pathophysiology of Fetal Hypoxia.
Describe stages of HIE (2006)10
10. Pathophysiology of Hypoxic Brain injury in neonate (2006/1)10
11. Discuss the pathophysiology of hypoxic Ischemic Encephalopathy (HIE) in neonates.(2009/1)10
12. Discuss etiology, pathophysiology, clinical manifestations and management of HIE (2013/2)10
13. Neuroprotective strategies in CNS injuries in neonates 5(2015/2)
14. Clinical features and management of HIE (2016/2) 5
15. Selective hypothermia for management of HIE (2019/1) 5
16. Therapeutic hypothermia. (2020/01)5
NEONATAL SEIZURES
1. Etiopathogenesis of neonatal seizures (2002/1)15
2. Management of Resistant Neonatal Seizure (2003/2)15
3. Classify neonatal seizures. Outline their etiology and provide a brief clinical description. Provide
general principles of management of a seizure in neonate. (2012/1) 2+2+3+3
4. Investigation and treatment of neonatal seizure (2018/2) 7
5. Approach to child with seizure in day 2 of life (2019/2)5
IVH
1. IVH (2003/1)15
2. Outline the risk factors, pathophysiology and principles of management of intraventricular
hemorrhage in preterm neonates. (2010/2)3+3+4
3. Discuss the pathogenesis of intracranial hemorrhage in newborn infants. Outline the possible
promoters and protectors for occurrence of subsequent white matter disease. (2012/1)6+2+2
4. Pathophysiology and management of intraventricular hemorrhage. 5(2015/2)
Chapter 121 Neonatal Resuscitation and Delivery Room Emergencies
1. Steps in Neonatal Resuscitation 15
2. How do you assign APGAR score to a neonate. In which 5 conditions will you get a low score
without associated hypoxia? What are fallacies of APGAR score. (2006)10
3. What is the sequence of events leading to the first breath after Delivery? What is the Significance
of establishment of Functional Residual Capacity? (2006)10
4. A term baby is apnoeic. What information of the perinatal events you would like to know?
5. What are the initial steps of management in the labor room? What are the possible complications
in the next 48 hours? (2008/2)10
6. Describe the changes taking place in circulation at birth and their implications in neonatal
resuscitation. (2009/1)5+5
7. Enumerate the newer recommendations of neonatal resuscitation by American Academy of
Pediatrics 2010 guidelines. Comment on the level of evidence for each of the changes. (2012/1)
6+4
8. Discus the recent changes in guidelines for resuscitation of new born and older children with the
rationale for the change. (2013/1)10
9. Recent NRP guidelines (2019/1) 5
Chapter 122 Respiratory Tract Disorders
1. Describe the surgical causes of Respiratory difficulty in newborn (2002/1)25
2. CPAP (2006/2)10
3. Write notes on embryological development of abdominal diaphragm and types of congenital
diaphragmatic hernia (2006) 10
29
DNBpedia ® 2021
2. Outline and discuss the strategies to prevent lung injury and bronchpulmonary dysplasia in a
preterm baby. (2013/1) 10
PPHN
1. Describe in brief PPHN (or PFC) with regard to Pathology, pathophysiology, Diagnosis and
management (1994/2)25
2. What is the etiopathogenesis of PPHN of Newborn. Outline the diagnosis and management
(2005)3+3+4
3. PPHN (2006/1)10
4. Discuss the diagnosis and management of PPHN (2007/2)
5. Enumerate causes of persistent pulmonary hypertension in neonates and discuss its
pathophysiology. (2008/1)10
6. Discuss the approach to diagnosis of Persistent Pulmonary Hypertension of Newborn (PPHN).
7. Outline the available modalities of management, highlighting their key features in a tabular
format. (2010/2)4+6
8. Etiology and management of persistent pulmonary hypertension. (2014/2) 3+7
9. Pathophysiology of persistent fetal circulation. (2015/1) 3
10. NO therapy in PPHN (2019/1) 5
11. Persistent pulmonary hypertension (PPHN) (2019/2) 5
Chapter 123 Digestive System Disorders
1. Enumerate causes of persistent vomiting in a 4 week old child. Describe clinical features and
management of hypertrophic pyloric stenosis. (2012/1)3+3+4
2. Describe the development of the midgut. Enumerate the causes for bilious vomiting in a two-week
old neonate and discuss its management. (2014/1) 3+2+5
NEONATAL JAUNDICE
1. Pathogenesis of kernicterus (1996/2)10
2. A 3-week old infant brought to the hospital with moderate jaundice. Discuss the Diagnosis
(1997/2)10
3. Kernicterus (1997/1)15
4. Discuss the Bilirubin metabolism and list the causes and approach to Diagnosis of
5. Hyperbilirubinemia in a neonate (2000/1)25
6. Discuss reasons for Physiological Jaundice in a Newborn. Define and list causes of
7. pathological jaundice in a newborn. Discuss clinical manifestations (acute and chronic) of
kernicterus (2006)10
8. Outline the normal metabolism of bilirubin. Outline the principle of phototherapy for treatment of
neonatal jaundice. List factors that influence efficacy of phototherapy. (2008/1)10 (2009/1)10,
(2010/2)4+3+3
9. Critically describe the role of various treatment modalities for treating neonatal unconjugated
hyperbilirubinemia. (2011/2)10
10. Outline and discuss various strategies to manage hyperbilirubinemia in newborns (2013/1)10
11. Short note on side effects of phototherapy (2014/2)5
12. Complications of unconjugated hyperbilirubinemia in a neonate (2015/2)5
13. Causes of prolonged hyperbilirubinemia in newborns. Outline steps of investigations and
management of it. (2016/2)
14. Mechanism of action of phototherapy in neonatal hyperbilirubinemia (2018/2) 5
NEC
1. Pathogenesis of NEC (1997/1) (1992)15
31
DNBpedia ® 2021
2. NEC (1997/2)15
3. Etiology and pathology of NEC 15
4. Etiology of NEC, staging and management. (2004/2)10
5. Discuss management of NEC (2006)5
6. Discuss the clinical features, diagnosis and management of neonatal necrotizing enterocolitis.
(2009/1)3+7
7. Discuss the pathophysiology, classification and diagnostic features of necrotizing enterocolitis.
(2010/2)4+3+3
8. A 6-day old preterm neonate presents with abdominal distension, feed intolerance, vomiting and
blood in stools. Discuss the differential diagnosis, diagnostic approach and principles of initial
stabilization. (2012/1) 4+3+3
9. Necrotizing Enterocolitis (NEC) - aetiology, staging and management. (2020/01)5
Chapter 124 Blood Disorders
1. Hemorrhagic Disease of The Newborn (1995/2)15
2. Management of Neonatal Thrombocytopenic Purpura (2000/1)15
3. Hydrops Fetalis (2003/1)15
4. What is Hydrops fetalis. Discuss etiology of Non immune hydrops fetalis. What is the
5. management of a case of Non immune hydrops fetalis (2005)2+5+3
6. Discuss etiopathogenesis, diagnosis and management of a Bleeding Neonate (2006/2)10
7. Anemia in newborn infant (2007/1)10
8. Non immune hydrops fetalis (2003/2)15, (2007/1)10
9. Define polycythemia in a newborn. What are the factors predisposing to it? Describe the impact of
polycythemia on various systems and their clinical presentation. Describe the management of
polycythemia in newborn. (2008/2)10
10. Outline the classification, clinical manifestations, laboratory findings and differential diagnosis of
vitamin K deficiency bleeding. (2012/1)3+3+2+2
11. A) Anemia of prematurity 5
B) Treatment options for a 3 month old preterm who has Hb of 6gm%. 5(2015/2)
12. Causes of Anemia in the Newborn (1993/1)10, (Apr 2016)5
13. Outline management of polycythemia 4(1/2016)
14. Clinical presentation of Vitamin K deficiency in newborn and neonates. Its prevention and
management (2016/2) 10
15. Management of HDN during 1st month of life (2017/2) 4
16. Discuss the approach to neonate with thrombocytopenia with specific reference to causes and
investigations (2019/2)6
Chapter 125 The Umbilicus
Chapter 126 Abstinence Syndromes
Chapter 127 The Endocrine System
1. New-born screening test in relation to endocrinology (2019/2)5
NEONATAL HYPOTHYROIDISM
1. Clinical features of Cretinism in newborn babies (1997/1)10
2. Describe in brief the etiology, clinical features, diagnostic investigations and management of
congenital hypothyroidism. (2011/1) 2+2+3+3
Chapter 128 Dysmorphology
1. Dysmorphic child (1994/2)15
Chapter 129 Epidemiology of Infections
32
DNBpedia ® 2021
33
DNBpedia ® 2021
34
DNBpedia ® 2021
36
DNBpedia ® 2021
37
DNBpedia ® 2021
3. What is atopic dermatitis? Describe clinical features, differential diagnosis and treatment of atopic
dermatitis. (2012/1)1+3+3+3
4. What are the types of Atopic Dermatitis (AD) in children? Discuss in detail the clinical features of
AD. Describe the differential diagnoses in a case of suspected AD. (2013/2) 2+4+4
5. A six-month old baby presents with rash over face and extensor aspect of extremities. Discuss the
diagnosis and treatment of this baby. (2014/1)5+5
Chapter 171 Insect Allergy
Chapter 172 Ocular Allergies
Chapter 173 Urticaria (Hives) and Angioedema
1. Drug treatment for Urticaria (2017/2) 4
Chapter 174 Anaphylaxis
1. Pathogenesis and management of anaphylaxis (1997/1)15
2. Mechanism, manifestations and management of anaphylaxis (1992)15
Chapter 175 Serum Sickness
Chapter 176 Food Allergy and Adverse Reactions to Foods
1. Immunological features associated with cow milk allergy 15
Chapter 177 Adverse Reactions to Drugs
38
DNBpedia ® 2021
Chapter 188 Hereditary Periodic Fever Syndromes and Other Systemic Autoinflammatory
Diseases
Chapter 189 Amyloidosis
Chapter 190 Sarcoidosis
Chapter 191 Kawasaki Disease
1. Kawasaki Syndrome (2000/1)15
2. Phases and complications of Kawasaki’s disease (2006)10
3. Discuss the presentation, diagnostic criteria for Kawasaki Disease. What is the management
strategy? What are the complications? (2008/1)10
4. Discuss the pathogenesis, differential diagnosis and echocardiography findings in Kawasaki Disease
(KD). How is the classical KD different from Atypical KD? (2009/1)6+4
5. Describe clinical manifestations of classical and atypical Kawasaki disease. Provide algorithmic
approach to a suspected case of Kawasaki disease. Enumerate various treatment modalities.
(2011/1)4+4+2
6. Write short notes on: Diagnostic criteria for Kawasaki Disease. (2013/2) 5
7. Algorithmic approach to a suspected case of Kawasaki disease. Enumerate its complications and
outline the management.5+2+3 (2015/2)
8. Treatment of Kawasaki disease (2017/2) 5
9. Therapy and follow-up of Kawasaki disease (2019/1) 5
10. Diagnosis and management of Kawasaki disease [2018/2]5
11. Role of salicylates in Kawasaki disease. (2020/01)5
Chapter 192 Vasculitis Syndromes
1. Classify vasculitis based on size of involved vessels and give examples of each category. Describe
etiology, clinical features and management of Takayasu’s arteritis. (2009/2)5+5
HSP
2. Discuss Briefly clinical presentation and management of H S Purpura (2007/1) 10
3. Describe the diagnostic approach and management of a six-year-old child presenting with purpuric
rash and pedal edema following an episode of acute diarrhoea. (2011/2) 4+6
4. HSP -clinical features and diagnosis (2018/2)5
5. Diagnosis and treatment of HSP (2019/1) 5
Chapter 193 Musculoskeletal Pain Syndromes
Chapter 194 Miscellaneous Conditions Associated With Arthritis
40
DNBpedia ® 2021
42
DNBpedia ® 2021
5. Define multidrug resistant (MDR) salmonella typhi (MDR – ST) and nalidixic acid resistant
salmonella typhi (NAFIRST). Discuss the mechanism of development of drug resistance for
salmonella typhi.(2008/1)10
Chapter 226 Shigella
Chapter 227 Escherichia coli
1. Discuss the pathogenesis of E. coli diarrhea (1994/2)15
2. Classification of E coli and pathogenesis of Invasive Diarrhoea (1995/1)15
Chapter 228 Cholera
Chapter 229 Campylobacter
Chapter 230 Yersinia
3. Management of Plague (1995/2)10
Chapter 231 Aeromonas and Plesiomonas
Chapter 232 Pseudomonas, Burkholderia, and Stenotrophomonas
Chapter 233 Tularemia (Francisella tularensis)
Chapter 234 Brucella
Chapter 235 Legionella
Chapter 236 Bartonella
SECTION 6 ANAEROBIC BACTERIAL INFECTIONS
Chapter 237 Botulism (Clostridium botulinum)
Chapter 238 Tetanus (Clostridium tetani)
Chapter 239 Clostridium difficile Infection
Chapter 240 Other Anaerobic Infections
SECTION 7 MYCOBACTERIAL INFECTIONS
Chapter 241 Principles of Antimycobacterial Therapy
Chapter 242 Tuberculosis (Mycobacterium tuberculosis)
1. Failure in control of Tuberculosis (1993/1)15
2. Prevention and early detection of TB (1996/2)15
3. Short course chemotherapy for TB (1998/2)10
4. DOTS chemotherapeutic management of Tuberculosis in National TB Control Programme
(2000/1)15
5. Diagnosis and management of a child with resistant TB (2002/1)15
6. CNS changes in Tubercular meningitis (Pathological only) 15
7. Discuss the pathogenesis, clinical symptomatology and diagnosis of NeuroTB (06)10
8. How do you perform and interpret Mantoux Test. Enumerate 3 conditions each in which you can
get a false positive and a false negative result. (2006)10
9. Newer diagnostic modalities for TB (2006)10
10. DOTS regimen and the problems involved in the implementation in childhood TB (2006) 10
11. What were the problems encountered in NTCP. Write the goals, strategies and essential
components of RNTPC. Also discuss in brief categorization of patients and treatment protocols
under RNTCP (2006)10
12. a) Describe the category based treatment in childhood TB (2009/2)3
b) Describe the pros and cons of intermittent therapy for tuberculosis (2009/2)3
43
DNBpedia ® 2021
46
DNBpedia ® 2021
8. Classify severity of dengue hemorrhagic fever. Write in brief the management of dengue shock
syndrome. (2011/1)4+6
9. What are the fluid, metabolic and biochemical changes in a child with severe dengue? Discuss the
underlying pathophysiology. (2013/1)10
10. Define severe dengue and describe the WHO guidelines for its management. Enumerate the
indications for transfusion in dengue. (2014/1)2+6+2
11. Define severe dengue. Describe the WHO guidelines for its management. Enumerate
complications of Severe Dengue 2+4+4 (Apr 2016)
12. Diagnostic lab tests for dengue fever (2018/1) 4
13. Definition and treatment of Dengue Hemorrhagic fever (2016/1) 3
14. Fluid therapy in DHF (2019/1) 5
15. Fluid management in Dengue Shock Syndrome and its complications (2019/2)5
Chapter 296 Yellow Fever
Chapter 297 Ebola and Other Viral Hemorrhagic Fevers
1. Describe the etiology, mode of transmission, clinical features and management of viral
hemorrhagic fever in children. (2012/1)2+2+3+3
Chapter 298 Lymphocytic Choriomeningitis Virus
Chapter 299 Hantavirus Pulmonary Syndrome
Chapter 300 Rabies
Chapter 301 Polyomaviruses
Chapter 302 Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome
1. Infants of HIV seropositive mothers (1995/1)15
2. Prevention of HIV infection during childhood (2002/1)15
3. HIV and Pediatrics (1998/2)10
4. Post exposure HIV prophylaxis (2003/2)15
5. An HIV positive mother has been admitted in labour. What will you do to prevent transmission of
infection to the baby (2005)10
6. Factors involved in perinatal transmission of HIV infection and the various preventive measures
(2006)10
7. Prevention of Childhood AIDS (2007/2)10
8. Clinical Presentations requiring screening for HIV (2007/1)5
9. HIV and TB (2007/1)5
10. Discuss the risk factors for vertical transmission of HIV infection and methods to prevent parent to
child transmission of HIV. (2009/1)4+6
11. Outline clinical and immunological criteria for starting anti-retroviral treatment (ART) in a HIV
infected child. How will you monitor a child initiated on ART? (2009/2)6+4
12. Enlist the common opportunistic infections in HIV infected children. Describe the clinical features,
diagnosis and management of herpes simplex infection in HIV infected children (2011/2)3+2+2+3
13. Discuss the available strategies for prevention of mother to child transmission of HIV. (2012/1)10
14. Enumerate opportunistic infections in HIV infected children. How will you treat and prevent
pneumocystis jiroveci infection? (2012/1)5+3+2
15. Briefly discuss the pulmonary disorders seen in children with HIV/AIDS. (2013/1)10
16. Discuss the key issues in the management of an HIV exposed infant. (2013/2)10
17. Strategies to prevent mother to child transmission of HIV infection (2017/1) 5
18. AIDS defining diseases in children (2016/2)
47
DNBpedia ® 2021
19. WHO guidelines for breastfeeding in a baby born to HIV positive mother (2019/1) 5
20. Anti-retroviral therapy in children (2019/1) 5
21. Dry blood PCR for HIV/AIDS testing (2019/1) 5
22. Treatment guidelines of neonate born to HIV positive mother (2018/2) 5
Chapter 303 Human T-Lymphotropic Viruses (1 and 2)
Chapter 304 Transmissible Spongiform Encephalopathies
SECTION 14 ANTIPARASITIC THERAPY
Chapter 305 Principles of Antiparasitic Therapy
SECTION 15 PROTOZOAN DISEASES
Chapter 306 Primary Amebic Meningoencephalitis
Chapter 307 Amebiasis
Chapter 308 Giardiasis and Balantidiasis
Chapter 309 Cryptosporidium, Cystoisospora, Cyclospora, and Microsporidia
Chapter 310 Trichomoniasis (Trichomonas vaginalis)
Chapter 311 Leishmaniasis (Leishmania)
1. Current therapy of Kala azar (2017/2) 5
Chapter 312 African Trypanosomiasis (Sleeping Sickness; Trypanosoma brucei Complex)
Chapter 313 American Trypanosomiasis (Chagas Disease; Trypanosoma cruzi)
Chapter 314 Malaria (Plasmodium)
1. Define drug resistant malaria, what are the different types of drug resistance as per WHO criteria.
Discuss the various management strategies of Drug resistant Malaria 25
2. Management of Cerebral Malaria 15
3. Malaria prophylaxis (1994/2)15
4. Drug resistant Malaria (2003/1)15
5. What are management guidelines of malaria under the national programme? How will you
6. manage a case of cerebral malaria. (2004/2)4+6
7. Enumerate manifestations of Severe Malaria and their management (2006/2)10
8. A 4-year-old girl presents with history of fever for 2 days associated with severe anemia, black
colored urine and splenomegaly. Discuss the management of this patient. (2008/2)10
9. Describe clinical manifestations of cerebral malaria. Enlist the differential diagnosis and
10. investigations required. Write management of a case of cerebral malaria in high endemic area.
(2009/1)(2+3+5)
11. Define complicated malaria. Describe the management strategies of complicated
malaria.(2009/2)3+7
12. Provide algorithms for case-detection and treatment for a child with fever, suspected to have
malaria, as per National Vector Borne Disease Control Program: (2010/2)5+5
13. Write short notes on: Laboratory diagnosis of malaria (2011/2) 5
14. List the WHO criteria to diagnose severe malaria. Discuss the management of a child with cerebral
malaria. (2013/1)4+6
15. Newer antimalarial drugs (2015/1) 4
16. Treatment of diagnosed cases of cerebral malaria (2018/1) 5
17. Clinical features, diagnostic tests and management of severe malaria in children (2017/1) 10
18. Recent National malarial treatment guidelines (2019/1) 5
48
DNBpedia ® 2021
49
DNBpedia ® 2021
child is stabilized what laboratory diagnosis would you do in this child. What is the Differential
Diagnosis and treatment of this condition (2005)10
3. Management of Acute Upper GI Bleeding (2006)10
4. Discuss the management of acute upper gastrointestinal bleeding in a 5-year-old child. (2008/1)10
5. Define hematemesis, malena and hematochezia.
A 3 years old child presents with sudden onset vomiting of blood. Describe the approach to this
child (including history and examination). Outline the steps of management. (2008/2)10
Chapter 353 Ingestions
SECTION 4 STOMACH AND INTESTINES
Chapter 354 Normal Development, Structure, and Function of the Stomach and Intestines
Chapter 355 Pyloric Stenosis and Other Congenital Anomalies of the Stomach
Chapter 356 Intestinal Atresia, Stenosis, and Malrotation
Chapter 357 Intestinal Duplications, Meckel Diverticulum, and
Other Remnants of the Omphalomesenteric Duct
Chapter 358 Motility Disorders and Hirschsprung Disease
1. Encopresis (1999/2)15
2. Discuss the treatment of the following: Persistent constipation (2014/1) 3
3. Treatment of functional constipation (2020/01)5
Chapter 359 Ileus, Adhesions, Intussusception, and Closed-Loop Obstructions
Chapter 360 Foreign Bodies and Bezoars
Chapter 361 Peptic Ulcer Disease in Children
1. What is H.Pylori Bacillus? How is it associated with chronic abdominal pain (1998/2)10
Chapter 362 Inflammatory Bowel Disease
Chapter 363 Eosinophilic Gastroenteritis
Chapter 364 Disorders of Malabsorption
1. Diagnosis of carbohydrate intolerance (1995/1)15
2. Define malabsorption. Enlist the generalized and specific malabsorption states. Discuss the
investigative plan for a child with generalized malabsorption. (2008/1)10
3. Causes investigations and treatment of child with suspected intestinal malabsorption (2016/2) 10
4. When to suspect and how to investigate malabsorption syndrome (2018/1) 5
CELIAC DISEASE:
1. Pathogenesis of Celiac Disease (1997/2)15
2. Diagnosis and management of a child with Celiac Disease (2006/1)10
3. Aetiopathogenesis and diagnosis of celiac disease (2007/2)10
4. Discuss evaluation of a child with suspected intestinal malabsorption. Describe genetics,
pathogenesis, clinical spectrum and extra intestinal manifestations of celiac disease. (13/2) 5+5
5. Pathophysiology, clinical manifestations and management of gluten sensitive enteropathy.
3+4+3(15/2)
6. Serological tests for celiac disease (2018/2) 5
7. Diagnosis of Celiac disease (2019/1) 5
8. Explain the pathogenesis and diagnosis of celiac disease. (2020/01)4
9. Define non-responsive celiac disease and refractory celiac disease. (2020/01)4+2
Chapter 365 Intestinal Transplantation in Children With Intestinal Failure
51
DNBpedia ® 2021
52
DNBpedia ® 2021
3. Diagrammatically represent the portal venous system and the sites of Porto-systemic vascular
anastomosis in portal hypertension. Discuss the types, cause and pathophysiology of portal
hypertension (2007/1)10
4. Treatment for variceal haemorrhage.
5. Clinical features and diagnosis of portal hypertension [2018/2]5
Chapter 395 Liver Transplantation
1. Liver transplantation. Indication and procedure (2019/1) 5
SECTION 7 PERITONEUM
Chapter 396 Peritoneal Malformations
Chapter 397 Ascites
1. Differential Diagnosis of Ascites in children (1993/1)10
2. Enumerate the causes and discuss the types, pathogenesis and evaluation of ascites in children.
(2011/2)2+2+3+3
Chapter 398 Peritonitis
Chapter 399 Epigastric Hernia
55
DNBpedia ® 2021
7. Differential diagnosis and management of acute stridor in a 2 years old child. (2010/1)3+7
8. A 2-year-old boy presents with fever, change of voice and stridor for 2 days. Outline the
9. differential diagnosis and management options. (2012/1)6+4
10. Management of ALTB (2017/2) 4
Chapter 413 Congenital Anomalies of the Larynx, Trachea, and Bronchi
1. Bronchogenic cysts (2018/2)5
Chapter 414 Foreign Bodies in the Airway
1. Diagnosis of Bronchial Foreign Body (1993/2)10
Chapter 415 Laryngotracheal Stenosis and Subglottic Stenosis
Chapter 416 Bronchomalacia and Tracheomalacia
Chapter 417 Neoplasms of the Larynx, Trachea, and Bronchi
Chapter 418 Wheezing, Bronchiolitis, and Bronchitis
1. Course and prognosis of Acute Bronchiolitis (1998/2)10
2. Define acute bronchiolitis. Describe its etiopathogenesis and characteristics features. Outline the
essential steps in management of bronchiolitis. (2010/2) 2+2+2+4
3. Recent advances in treatment of bronchiolitis (2018/2) 5
4. Management of recurrent/persistent wheezing in children [2018/2]5
5. Management of Bronchiolitis (2019/1) 5
Chapter 419 Plastic Bronchitis
Chapter 420 Emphysema and Overinflation
Chapter 421 α1-Antitrypsin Deficiency and Emphysema
Chapter 422 Other Distal Airway Diseases
Chapter 423 Congenital Disorders of the Lung
1. Describe the congenital malformations of the lungs. Discuss the diagnosis and management of
these malformations (1996/2)25
2. Detail the causes for localized emphysema of the lung. Describe the presentation and
management of congenital lobar emphysema. (2008/1)10
Chapter 424 Pulmonary Edema
Chapter 425 Aspiration Syndromes
Chapter 426 Chronic Recurrent Aspiration
1. List conditions predisposing children to Aspiration Lung injury. Mention clinical features and
principles of management of Chronic Aspiration. Conditions predisposing children to aspiration
lung injury (2007/2)10
Chapter 427 Immune and Inflammatory Lung Disease
1. Diagnosis and treatment of Bronchopulmonary aspergillosis (2018/1) 5
Chapter 428 Community-Acquired Pneumonia
2. Treatment of Staphylococcal pneumonia (1993/1)10
3. Discuss Briefly the Differential diagnosis and management of a case of Persistent Pneumonia in a 3
month old infant (1999/2)15
4. Discuss differential diagnosis and management of a child with recurrent pneumonia. (2011/2)4+6
5. WHO Classification of community acquired pneumonia in children less than 5 years of age
(2018/1) 5
6. Causes and investigations for persistent pneumonia. (2018/1)5
7. Causes and investigations of persistent pneumonia (2019/2)5
57
DNBpedia ® 2021
58
DNBpedia ® 2021
Chapter 457 Cyanotic Congenital Heart Disease Lesions Associated With Decreased Pulmonary
Blood Flow
1. Cyanotic Spell (1994/2)15
2. How do you classify congenital cyanotic heart disease? Discuss their investigations (1997/2)15
3. Complications of Fallot’s Tetralogy and their management (1999/2)10
4. Management of Paroxysmal Hypercyanotic spell (1999/2)15
5. Pathophysiology of Cyanotic spells (2002/1)15
6. What are the congenital heart diseases associated with cyanotic spells. Write clinical
7. presentation and management of cyanotic spell. (2004/2)2+3+5
8. How will you manage a child in cyanotic spell (2006)5
9. Pathophysiology, diagnosis and treatment of Eisenmenger Syndrome (2007/1)10
10. Discuss the hemodynamics and pathophysiology of Tetralogy of Fallot. Outline management of
cyanotic spell in a 2-year-old child. (2012/1)4+3+3
11. Describe the hemodynamics and clinical features of tricuspid atresia in a neonate. Outline the
expected findings on ECG and chest X-ray. (2013/1) 3+3+2+2
12. Causes of blue spells in neonates (2017/2) 6
13. Complications of TOF (2017/2) 5
14. Pathophysiology and treatment of cyanotic spells. (2018/1) 5, (2019/1)
Chapter 458 Cyanotic Congenital Heart Disease Lesions Associated With Increased Pulmonary
Blood Flow
1. Clinical features and management of Hypoplastic left heart syndrome (2016/2) 5
Chapter 459 Other Congenital Heart and Vascular Malformations
Chapter 460 Pulmonary Hypertension
1. Pathophysiology of Eisenmenger syndrome (2018/2)5
Chapter 461 General Principles of Treatment of Congenital Heart Disease
1. Discuss the various minimally surgical invasive devices and procedures available for the
management of common congenital heart diseases in children. (2007/1)10
60
DNBpedia ® 2021
11. Enumerate difference between sinus tachycardia and SVT in a tabular format (2017/2) 4
12. Management of SVT (2019/1) 5
13. Approach to arrhythmia in children (2019/2)5
Chapter 463 Sudden Death
14. Recent understanding of SIDS (1994/1)15
SECTION 5 ACQUIRED HEART DISEASE
Chapter 464 Infective Endocarditis
1. Pathogens, clinical features and management of infective endocarditis. (2010/1)2+4+4
2. Enumerate common pathogens of infective endocarditis. List conditions/ interventions which
require prophylaxis for infective endocarditis in a child with underlying heart disease. Outline
antibiotic therapy for a child with RHD and infective endocarditis. (2011/1)2+3+5
3. Outline Duke criteria for diagnosis of bacterial endocarditis. Discuss its application in clinical
setting. (2013/1)6+4
4. Infective endocarditis prophylaxis in heart disease [2018/2] 5
Chapter 465 Rheumatic Heart Disease
1. Treatment of Acute Rheumatic carditis (1997/1)15
61
DNBpedia ® 2021
10. Discuss the role of vasodilator therapy in congestive heart failure. Enumerate various vasodilator
agents used in CHF and their respective mechanisms of action. (2008/1)10 4+3+3(2015/2)
11. A 13-year-old male is brought with an H/o progressive Dyspnea on exertion. He has past H/o
recurrent joint pain. What is the most likely diagnosis? How will you investigate and manage the
child? Add a note on Refractory CCF in a child (2005)5+5
12. List the causes of congestive heart failure in a 2 years old child. Describe different types of VSD
according to position and size. Write indicators for surgical intervention/ device closure.
(2008/1)10
13. A 3-year-old child having fever for 2 days suddenly develops breathlessness, tachycardia and
sweating. Describe the differential diagnosis of this case and its treatment. (2009/2)5+5
14. A 2-month old baby presents with history of failure to gain weight, tachypnea, tachycardia,
difficulty in taking feed and excessive perspiration. On examination –no cyanosis, hepatomegaly
and systolic murmur is noted. Discuss differential diagnosis, investigations and management.
15. Management of congestive heart failure (2017/2) 5
Chapter 470 Pediatric Heart and Heart-Lung Transplantation
SECTION 8 DISEASES OF THE PERIPHERAL VASCULAR SYSTEM
Chapter 471 Diseases of the Blood Vessels (Aneurysms and Fistulas)
Chapter 472 Systemic Hypertension
1. Diagnosis of Essential Hypertension in children (1993/1)10
2. Investigations in a child with Hypertension (1995/1)10
3. Treatment of Hypertension (1997/2)12
4. Discuss etiology, diagnosis and management of Childhood Hypertension (2000/1)25
5. Severe Hypertension in infancy (2000/1)15
6. Discuss the causes of Hypertension in a 7-year-old child. Approach of investigation and
management of such a case (2002/1)25
7. A 8 year old child is brought with a history of convulsions and altered sensorium. On examination
her BP was 180/110 mm Hg. Discuss the D/D and laboratory investigations in this child. Discuss the
management of Hypertensive Encephalopathy in this child. Add a note on fundus changes in
hypertension. (2006)10
8. Recent advances in management of Hypertension (2006/1)10
9. Essential Hypertension in children (2007/1)10
10. Discuss the treatment of Hypertension in children. Classify the drugs used to treat hypertension
and Briefly mention their mechanism of action (2007/2)10
11. A 10 year old boy is brought with a history of convulsions and altered sensorium. On examination,
his BP was 180/110 mm of Hg. Describe differential diagnosis, laboratory investigations and
treatment of this case. (2009/2)3+4+3
12. Describe the causes and pathogenesis or renal and renovascular hypertension. Outline principles
of management. (2012/1)3+3+4
13. Define Hypertension in children. Enumerate the causes and discuss the management of an 8 years
old boy presenting with a blood pressure of 210/160 mm Hg with seizures. (2014/1)2+3+5
14. An 8-year-old child is brought with a history of convulsions and altered sensorium. His BP is
180/110 mm Hg. Discuss the D/D and laboratory investigations and management of this patient.
3+3+4(Apr 2016)
15. Treatment of hypertensive emergency (2018/1) 5
16. Recent advances in the diagnosis and management of high blood pressure in children. (2020/01)5
62
DNBpedia ® 2021
63
DNBpedia ® 2021
6. Write short note on: Peripheral smear findings in iron deficiency and B12 deficiency anemia
(2010/2)2.5+2.5
7. Diagnostic and management of Megaloblastic anemia (2019/1) 5
Chapter 482 Iron-Deficiency Anemia
1. Prevention of Iron Deficiency Anemia in children (1995/2)15
2. Management of Iron Deficiency anemia (1998/2)10
3. Enlist the causes and outline the Differential Diagnosis and treatment of iron deficiency anemia
(2005)3+3+4
4. Outline the etiology of iron deficiency in children. Describe the clinical features and approach to
diagnosis of a child suspected to be having nutritional anemia. (2013/1)3+(2+5)
5. Describe the sequential pathological changes seen with iron deficiency states. What laboratory
studies can be used to differentiate common microcytic anemias? (2013/2) 5+5
6. Prevention of iron deficiency anaemia in children under 5 years of age [2018/1/5]
Chapter 483 Other Microcytic Anemias
1. Differential diagnosis of microcytic hypochromic anaemia [2018/2]5
64
DNBpedia ® 2021
8. List the causes of microcytic hypochromic anemia. Provide differentiating features between iron
deficiency anaemia and beta thalassemia trait. Describe the management of thalassemia major.
(2011/1)3+3+4
9. Outline the long term complications of thalassemia major. How will you monitor for such
complications in a child with thalassemia major? (2013/1)5+5
10. Describe the foetal hemoglobins. Discuss the transfusion therapy for Thalassemia major and its
long term follow up plan. (2014/1)3+4+3
11. Recent concepts/advances for treatment /management of Thalassemia major in children
(1995/2)10, (2014/2)5
12. Advances in treatment of Thalassemia major (2016/2) 5What are the usual patterns in
haemoglobin electrophoresis in beta thalassemia syndromes? [2018/1]
13. Iron chelation therapy (2017/1) 5, (2019/1) 5
14. Indication of splenectomy in thalassemia [2018/2]5
15. Counselling of an antenatal mother who has a thalassemia major child (2019/2)4
Chapter 490 Enzymatic Defects
1. Pathogenesis of anemia in G6PD Deficiency (1999/1)15
2. G6PD deficiency (1999/2)10
3. 3-year-old Child-H/O Jaundice since 2 months, H/O Exchange transfusion at D2. Discuss the D/D.
Classify Hemolytic Anemia. Add a note on management of Intravascular hemolysis in G6PD
deficiency (2005)4+4+2
4. Briefly outline normal erythropoiesis. Describe the diagnosis and treatment of G6PD deficiency
(2007/2)10
5. Enlist the red blood cell metabolic enzyme pathways and the enzymes responsible for hemolysis.
Discuss the pathogenesis involved in these hemolytic anemias. (2011/1)3+7
Chapter 491 Hemolytic Anemias Resulting from Extracellular Factors—Immune Hemolytic
Anemias
1. Discuss the etiology and management of Autoimmune Hemolytic Anemia (2009/1)3+7
2. Discuss the etiology, pathogenesis and diagnostic workup of Acute autoimmune hemolytic
anemia. (2010/2)3+3+4
3. Diagnosis and management of Autoimmune Hemolytic Anemia 3(2015/1)
Chapter 492 Hemolytic Anemias Secondary to Other Extracellular Factors
2. Define pancytopenia. Enlist the causes and assessment of severity of aplastic anemia in children.
(2010/1)2+4+4
3. Define pancytopenia. Enumerate common causes in children. How will you assess severity of
acquired anemia in children? (2011/2)2+3+5
4. Evaluation of child with pancytopenia (2020/01)5
66
DNBpedia ® 2021
68
DNBpedia ® 2021
69
DNBpedia ® 2021
Chapter 537 Isolated Glomerular Diseases Associated With Recurrent Gross Hematuria
1. Discuss the pathogenesis, clinical features and management of acute PSGN
2. Enumerate the complications of acute post – streptococcal glomerulonephritis. Describe their
management in brief. (2010/2) 3+7
3. Etiopathogenesis of RPGN (2017/2) 6
Chapter 538 Multisystem Disease Associated With Hematuria
1. Diagnostic features of HUS (1993/2)15
2. HUS- etiopathogenesis and diagnosis (1998/1)15
3. Classify Haemolytic Uremic Syndrome. Discuss its pathogenesis, clinical features and management.
(2013/2)2+3+3+2
4. Classification, etiopathogenesis and management of hemolytic uremic syndrome. (2016/1)3+4+3
5. Management of HUS (2017/2) 4
6. Diagnosis and management of hemolytic uremic syndrome. (2020/01)5
Chapter 539 Tubulointerstitial Disease Associated With Hematuria
Chapter 540 Vascular Diseases Associated with Hematuria
70
DNBpedia ® 2021
71
DNBpedia ® 2021
5. Enumerate renal tubular functions and describe the tests to evaluate tubular disorders for the
proximal tubule. How will you treat a child with proximal renal tubular acidosis? (2014/1)3+4+3
6. Diagnosis and management of Distal renal tubular acidosis. 5(1/2016)
Chapter 548 Nephrogenic Diabetes Insipidus
1. Nephrogenic Diabetes Insipidus (1998/2)15
Chapter 549 Inherited Tubular Transport Abnormalities
1. Discuss etiopathogenesis, clinical manifestations and management of Bartter Syndrome. (2013/2)
Chapter 550 Renal Failure
ARF:
1. What are the causes of ARF in children? How will you investigate such a case? Discuss
management. (1997/1)25
2. What are the causes of acute renal failure in a 4-year-old child. How will you investigate such a
case? Discuss the management of acute renal failure. (2004/2)4+3+3
3. Outline the etiopathogenesis of ARF in children. Discuss Briefly the management (2005)5+5
4. List the causes of renal failure in a 3-month old child. Discuss the clinical features, laboratory
diagnosis and treatment of acute renal failure in children. Discuss the indications of renal biopsy in
children (2006)10
5. Discuss the etiology of cortical necrosis in newborns and older children, separately. State the most
important clinical manifestations of cortical injury and factors governing prognosis. (2008/1)10
6. What is acute renal failure? List the common causes leading to it. Tabulate the laboratory indices
used to differentiate pre-renal and intrinsic acute renal failure. Outline the medical management
of acute renal failure. (2008/1)10
7. Write short notes on: (2013/1)
a. Pediatric RIFLE criteria for acute kidney injury 5
b. Urinary indices in acute renal failure 5
8. Pathophysiology, causes, clinical features and management of acute renal failure (2017/1) 5
9. Investigations and management of AKI (2019/2)7
CRF:
1. Biochemical and endocrinal changes in CRF
2. Describe the pathogenesis of CRF and outline important principles in the management of such a
case (1995/2)25
3. Discuss the role of recombinant human erythropoietin therapy (indication, dose, aim, precaution,
benefits and complications) in management of chronic renal failure. List reasons of resistance to
such therapy. (2008/1)10
4. Define renal osteodystrophy. Enumerate its clinical features and outline the management.
(2009/2)2+3+5
5. Define Chronic kidney Disease (CKD) and its stages. What are the clinical manifestations of CKD.
Outline its treatment. (2013/2) 3+4+3
6. Renal osteodystrophy [2018/2] 5
7. Renal osteodystrophy. (2020/01)5
RENAL REPLACEMENT THERAPY
1. Renal replacement therapy in ESRD (2000/1)15
2. Peritoneal dialysis (2003/1)15
3. Renal replacement therapy (2006/1)10
4. Discuss renal replacement therapy (2007/1)10
Chapter 551 Renal transplantation
72
DNBpedia ® 2021
74
DNBpedia ® 2021
75
DNBpedia ® 2021
76
DNBpedia ® 2021
3. Define and classify precocious puberty in boys according to its etiology. Outline the approach for
investigating a boy with precocious puberty. (2011/1)2+4+4
4. Define delayed puberty. Describe its etiology and diagnostic evaluation. (2013/2)2+4+4
5. Write short notes on the evaluation and treatment for a child with: Virilisation (2014/1)
6. Define precocious puberty in boys. Enumerate causes of precocious puberty in boys (2014/2)5
7. Approach to delayed puberty (2017/2)5
8. Diagnostic approach to precocious puberty in girls (2018/2)5
9. Premature thelarche (2018/1)4
10. Investigation and management of delayed puberty (2019/2)5
11. Precocious puberty. (2020/01)5
77
DNBpedia ® 2021
1. A 1 ½ year old female is brought to you with obesity, short stature, hypertension and
hypertrichosis of face and trunk. Provide differential diagnosis and approach to investigating and
managing this child. (2009/1)3+7
Chapter 598 Primary Aldosteronism
Chapter 599 Pheochromocytoma
1. Clinical features, investigations & treatment of pheochromocytoma. (2010/1)3+3+4
79
DNBpedia ® 2021
9. Classify severity of diabetic ketoacidosis on the basis of clinical and blood gas examination. Briefly
describe Somogyi and Dawn phenomenon in type 1 diabetes. (2008/1)10
10. Discuss the metabolic changes associated with diabetic ketoacidosis with steps of treatment of
diabetic ketoacidosis. (2008/2)10
11. A 10-year-old child (body weight 22kg) presents with severe diabetic ketoacidosis. Write down the
expected clinical and investigate findings. Outline the plan of management in first 24 hours.
(2009/1)4+6
12. Discuss the pathophysiological abnormalities in diabetic ketoacidosis. Describe the management
of diabetic ketoacidosis in a child weighing 20 kg. (2013/2) 4+6
13. What are the biochemical criteria for the diagnosis of Diabetic Ketoacidosis (DKA)? What are the
goals of therapy? How will you manage a 7-year-old child with DKA? (11/2)3+3+4
14. Hyperosmolar non ketotic diabetic coma 5(1/2016)
15. Diagnosis and complication of Metabolic syndrome 4(1/2016)
16. A. What are the biochemical criteria for the diagnosis of Diabetic Ketoacidosis (DKA)?
B. What are the goals of therapy?
C. How will you manage a child with DKA? 3+2+5(1/2016)
17. Commonly used insulin regimens for long-term treatment of DM type 1 (2017/2) 5
18. Management of treatment of diabetes at home (2019/1) 5
19. Management of diabetic ketoacidosis (2018/) 5
20. Long-term management of Type 1 diabetes mellitus. (2020/01)5
80
DNBpedia ® 2021
81
DNBpedia ® 2021
1. Define craniosynostosis and its types. Name specic syndromes associated with craniosynostosis.
Describe the clinical characteristics of common types of craniosynostosis. (2013/2)3+3+4
NEURAL TUBE DEFECTS
1. Prevention of Neural Tube Defects (1997/2)15
2. Role of Folic Acid in prevention of Neural Tube Defects (1998/2)10
3. Discuss briefly the possible predisposing factors, types of open Neural Tube Defects in children
and its prevention (2007/1)10
4. Enumerate various types of neural tube defects and discuss their embryogenesis. Outline in brief
management of meningomyelocele. (2011/1) 3+3+4
5. Enumerate common types of neural tube defects. Discuss prevention and management of neural
tube defects. (2014/2)4+(2+4)
6. Neural tube defects [2018/1]
NEURONAL MIGRATION DISORDERS:
1. Enumerate 4 common neuronal migration disorders and their clinical features in brief 6(01/2016)
2. Disorders of neuronal migration [2018/2]5
Chapter 610 Deformational Plagiocephaly
Chapter 611 Seizures in Childhood
1. Benign Rolandic Epilepsy of Childhood (1993/1)15
2. Management of children with partial epilepsy (1995/1)15
3. Management of Children with Partial Seizures (1995/1)15
4. Classification of Epilepsy and treatment of Simple Partial Seizures (1996/2)12
5. What are the causes of convulsions in infancy and childhood How will you investigate such a case
(1997/2)15
6. Management of a case of Complex Partial Seizure (1998/2)10
7. Infantile spasms (1999/2)10
8. Partial Seizures 15
9. Approach to an infant with myoclonic seizures (2000/1)15
10. Diagnosis and management of a child with Partial Focal Seizure (2006/2)10
11. Define myoclonic epilepsy. Discuss in brief the characteristic features of different types of
myoclonic epilepsies, with onset in infancy. (2010/2)2+8
12. Enumerate the etiology of first episode of complex partial seizures in a 7-year-old boy. Provide an
approach to management of this child. (2011/1)4+6
13. Describe the etiology, types and EEG changes of infantile spasms. Outline the treatment protocol.
(2012/1)2+3+1+4
14. Epilepsy syndromes with focal seizures [2018/1/5]
15. Define epilepsy. How are seizures classified (2019/1)
16. Role of EEG in management of seizure disorders in children (2020/01)5
17. Landau Kleffner Syndrome (2020/01)5
FEBRILE SEIZURE
1. Definition, prognosis and management of Febrile Convulsion (1993/1)15
2. Etiology and management of Febrile Seizures (1998/1)15
3. Define Febrile Convulsions. Discuss the management of a 2-year-old child who presents to the
emergency room with rst episode of Febrile Seizure. Add a note on anticonvulsant
4. Prophylaxis in febrile seizure. (2006)10
82
DNBpedia ® 2021
5. Write the characteristic features of febrile seizures in children. Enumerate the differentiating
points for atypical febrile seizure. Outline the indications and regime for continuous prophylaxis in
febrile seizures. (2010/2)2+2+3+3
6. Describe various types of febrile seizures [2018/1/4]
STATUS EPILEPTICUS
1. Treatment of Status Epilepticus in a 5-year-old Child (1995/2)10
2. What are the causes of Convulsions in children? Discuss the management of Status Epilepticus
(2005)5+5
3. An 8-year-old apparently well boy presents with generalized seizures for the last one hour. How
will you approach (including history and examination) this child? Discuss the management of this
patient. (2008/2)10
4. Steps in management of status epilepticus in children. (2017/1) 5, (2016/2) 10
5. Management of refractory status epilepticus (2019/2)5
Chapter 612 Conditions That Mimic Seizures
1. Pseudo seizures (1998/2)10
2. Conditions mimicking seizures (1999/2)15
3. Discuss conditions that mimic seizures in children (2007/2)10
Chapter 613 Headaches
1. Define Migraine in children. Discuss the Classification of Migraine and write its management
(2007/2)10
2. Classification and management of Migraine (2007/1)10
3. List causes of headache in children. Outline an approach for a 10-year-old child with headache.
(2011/1)4+6
4. Classification of headache disorders in children (2017/2) 4
Chapter 614 Neurocutaneous Syndromes
1. List the neurocutaneous syndromes. Describe the genetics, cellular defect, clinical manifestation
and diagnosis of tuberous sclerosis. (2009/2) 3+1+1+3+2
2. Neurocutaneous syndrome (2019/2)5
Chapter 615 Movement Disorders
1. Enumerate the causes for ataxia in children. Discuss the investigations and treatment for a 7 year
old boy presenting with acute onset ataxia. (2014/1) 4+3+3
2. Management of infantile tremor syndrome (1/2016)4
3. List common movement disorders in children (2017/2) 3
4. Acute cerebellar ataxia. (2020/01)5
Chapter 616 Encephalopathies
1. Describe evaluation of a child with cerebral palsy. (2009/2)10
2. Enumerate management of CP (2019/1) 5
3. Diagnosis of autoimmune encephalitis (2019/1) 5
Chapter 617 Neurodegenerative Disorders of Childhood
1. Discuss the diagnosis and investigation plan for a 2 year old child with regression of milestones
and generalized seizures (1993/1)25
2. Enlist the possible conditions which could result in a 24 month old child with history of regression
of milestones for past 8 month. The child also has a liver enlargement. Detail the clinical
manifestation of Tay Sach Disease? (2008/1)10
3. A 2-year-old child presents with history of regression of milestones for past 6 months and
hepatosplenomegaly. Discuss the differential diagnosis and diagnostic approach. (1/2016)
83
DNBpedia ® 2021
85
DNBpedia ® 2021
86
DNBpedia ® 2021
88
DNBpedia ® 2021
89
DNBpedia ® 2021
90
DNBpedia ® 2021
91
DNBpedia ® 2021
92
DNBpedia ® 2021
93
DNBpedia ® 2021
2. Outline the pre-hospital and hospital management of a 10-year-old boy bitten by a poisonous
snake. (2009/1)10
3. A 4-year-old child has been bitten on his foot by a snake. How is a poisonous snake identified?
Discuss the management of this child. (2014/1)3+7
4. Clinical manifestations and management of viper bite (2016/1) 5
5. Snake bite poisoning -clinical features (2018/2)5
95
DNBpedia ® 2021
96
DNBpedia ® 2021
SOCIAL PEDIATRICS
1. Discuss briefly the major goals for child survival and development by 2000AD (1997/1) 25
2. What measures can reduce Birth Rate in next 5 years (1998/2) 10
3. Objectives and strategies of ‘Maternal Child Survival And Safe Motherhood Programme’
(1994/2)15
4. Child health care services provided through CSSM programme in India (1995/1)15
5. CSSM Programme (1996/2)15
6. National AIDS control Programme in preventing Childhood AIDS (2006/1)10
7. National Leprosy Eradication Programme 15
8. National Iodine Deficiency Disorder Control Programme (2007/2) 10
9. What is the Birth Weight specific mortality? Discuss the measures to reduce this mortality
(2005)10
10. Enumerate chief causes of neonatal mortality in India. Describe the current status in India and its
status. Prepare a 5-year plan for reduction of neonatal mortality rate in your district. (2008/1)10
11. List and Define the important public health indicators of mortality in children. Also discuss their
current status in India. (2009/1)7+3
12. What are the major contributors to the high infant mortality in our country? What Specific areas
of infant or/and newborn care can be strengthened to decrease infant mortality in India. Describe
the salient features of the integrated management of neonatal and childhood illness strategy.
(2009/2) 2+3+5
13. Enumerate the Millennium Development Goals. Describe briefly the National Health Programs to
achieve Millennium Development Goals (MDG) in India. Write the status of India in relation to
health indicators in NHFS – 3. (2010/1)2+4+4
14. Define under – 5 mortality rate. Comment on its current status and etiology in India. Outline
important strategies/ programs undertaken by Govt. of India to improve Under 5 child survival.
(2010/2) 2+2+2+4
15. Define various indicators of child health which are important in context of monitoring child health
in a developing country. Outline the interventions to reduce them. (12/1)5+5
16. Write short notes on: (2013/2) 5+5
17. a) ASHA
b) MDG (millennium Development Goal) focused on children.
18. Mission Indradhanush 3 (2015/1)
19. Iron plus initiative 3(2015/1)
20. Write short notes on: (2013/2)5+5
a) Mid Day Meal programme
b) Revised National Cancer Control programme.
21. A) Millenium development goals 4 (Apr 2016)
B) Swachh Bharat Abhiyan 3
22. Sustainable development goals relevant to children (2018/1) 4
23. Infant mortality rate in India- current status (2017/2) 5, (2018/2) 5
24. Major causes for neonatal mortality and morbidity in India (2017/2) 4
25. First Referral Unit – FRU (2016/2) 2
26. Rashtriya Bal Swasthya Karyakram (RBSK) (2017/2) 6, (2019/1) 5
27. POCSO Act 2012 (2017/2) 4
28. Mission Indradhanush [2018/1/5], (2016/2) 3
29. Child health screening and early intervention services in RBSK (2016/2)
97
DNBpedia ® 2021
30. Objectives and components of National Iodine Deficiency Disorders Control Program (2016/2)
31. Infant Young and child feeding strategy (2019/1) 5
32. National neonatal screening program (2019/1) 5
33. Components of NRC [Nutrition Rehabilitation Centre] [2018/2]5
34. Home based newborn care (2019/2) 4
35. Discuss Anemia Mukt Bharat with specific reference to children and adolescents (2019/2)5
36. INAP (India Newborn Action Plan) (2019/2)5
37. District early intervention centre (DEIC) (2019/2)5
38. Neonatal mortality rate- Current status in India (2019/2)5
RCH
1. Use of Road to Health Charts in MCH clinics (1995/2)10
2. RCH programme (1998/2)15
3. National targets for MCH services 15
4. Pediatric components of RCH programme (1999/2)15
5. RCH Programme-aims and strategies (2002/1)15
6. Community management of Diarrhea and LRTI with indications for referral (2002/1)15
7. RCH Programme in India (2006)10
ICDS
1. ICDS scheme (1997/2)15
2. Outline the components of ICDS programme. Briefly discuss its impact on child health in India and
also causes for its failure. (2004/2)3+4+4
IMNCI
1. IMNCI (2003/2)15
2. IMNCI- what is the strategy. Discuss the factors in successful implementation of this strategy
(2005)5+5
3. What is IMNCI? What are the various criteria and limitations of this Programme? Elaborate signs,
symptoms and diseases covered under this programme (2006)10
4. How do you classify the severity of acute respiratory infections using the IMNCI protocol?
(2006)10
5. Describe briefly the principles of integrated management of neonatal and childhood illness
(IMNCI). Outline the broad steps of case management process. (2008/1)10
6. Outline the essential components and principles of IMNCI strategy. Highlight the cardinal features
of case management process of young infants (<2 months) (2009/1)4+6
7. Discuss the justification for the addition of neonatal component to WHO generic IMNCI
programme for making IMNCI strategy. What are the key features of this strategy? (2011/2)5+5
8. Enumerate the five high impact activities under RMNCH+ A programme 2x5 (Apr 2016)
POLIO ERADICATION
1. Pulse Polio Immunization (1996/1)15
2. a) Define polio eradication
b) Polio eradication in india.
c) Immunisation issues following polio eradication. (2015/1) 1+2+3
3. Current WHO guidelines of AFP surveillance (2019/1)
RNTCP
1. Failure in control of Tuberculosis (1993/1)15
2. DOTS chemotherapeutic management of Tuberculosis in National TB Control Programme
(2000/1)15
98
DNBpedia ® 2021
3. DOTS regimen and the problems involved in the implementation in childhood TB (2006)10
4. What were the problems encountered in NTCP. Write the goals, strategies and essential
components of RNTPC. Also discuss in brief categorization of patients and treatment protocols
under RNTCP (2006)10
5. a) Describe the category based treatment in childhood TB (2009/2)3
b) Describe the pros and cons of intermittent therapy for tuberculosis (2009/2)3+3
c) What are the components of DOTS strategy as Defined by WHO? (2009/2)4
6. Describe the ow chart for diagnosis of childhood tuberculosis under RNTCP. Write briefly on DOT
PLUS program. (2012/1) 6+4
7. A) Define DOTS, DOTS agents and DOTS plus.
B) List at least 4 important components Of DOTS
C) Give the categorization of treatment strategy in DOTS.(2015/1)3+2+5
NHM/ NRHM
1. Write a short note on National Rural Health Mission (2007/1)(2009/2)10
2. Expand the acronym ‘ASHA’. Outline the functions and remuneration of ASHA. Discuss the
potential impact of ASHA in improving the health status and wellbeing of a community.
(2011/1)1+4+5
3. ASHA 4(1/2016)
4. ASHA -roles and responsibilities in brief (2018/2)5
BFHI
1. Baby Friendly Hospital Initiative (1995/2)15
2. Briefly describe “baby friendly hospital initiative” and list ten steps to successful breast feeding.
(2008/1)10
3. What is BFHI (Baby Friendly Hospital Initiative)? Mention its aims and objectives, steps, benefits
and assessments of baby friendly hospitals. (2011/2)2+2+2+2+2
4. Outline the goals of baby Friendly Hospital Initiative (BFHI). Enumerate ten steps to successful
breast feeding. Mention contraindications to breast feeding. (2013/1)2+5+3
BIOMEDICAL WASTE MANAGEMENT
1. Hospital Waste Management (2006)10
2. Discuss safe injection practices at a level three health care facility. Outline the management of a
needle stick injury to a health care provider 10 minutes back. (2008/2)10
3. Define ‘biomedical waste’. Briefly categorize them. Enumerate their health hazards. List 4
important methods for disposal of biomedical wastes. (2008/1)10
4. Define biomedical waste. Describe its hazards. Outline modes of disposal of biomedical waste
generated in a hospital setting. (2012/1)2+3+5
5. Safe injection practices at level III care with respect to burden / deficiencies, risks, technique,
handling and disposal 2+2+2+2+2 (2015/2)
6. Safe injection practices [2018/2]5
7. What are the safe injection practises (2019/1) 5
99
DNBpedia ® 2021
PHARMACOLOGY
IMMUNOGLOBULIN
1. Indications for using IV immunoglobulin in children (1997/1)10
2. Role of IVIG in pediatric practice (2000/1)15
3. Indications for use of IV Immunoglobulin in Pediatric Practice (2006)10
4. Briefly outline the uses for I v immunoglobulin (IVIG) in children. (2007/2)10
5. Enlist the common indications for the use of IVIG.. Describe the mechanism of action, doses and
its side effects. (2010/1)3+3+2+2
6. Describe in brief the diseases in which IVIG is used for treatment. Write the dosage, administration
and side effects of IVIG. (2010/2) 5+2+1+2
7. Discuss indications and plausible mechanisms of action of intravenous immunoglobulin therapy in
various pediatric disorders. (2013/2)10
8. Indication, mode of action and side effects of IVIG in Paediatric practise (2017/1) 10, (2016/2) 5,
(2019/1)
INTERFERON
1. Clinical importance of Interferon (98/2)10
2. Pegylated interferons (2016/2)
NO
1. Physiological basis and therapeutic basis of NO (1998/2)10
2. Clinical use of NO (2003/2)15
CHELATING AGENTS
1. Oral chelating agents (1994/2)15
2. Iron chelation therapy (2006) (2000/1)5
3. Iron chelating agents in Pediatric practice. (2020/01)5
ANTIBIOTICS
4. Describe various mechanisms for development of Drug Resistance by bacterial pathogens against
antibiotics. What factors are known to enhance drug resistance? Enumerate Anti Staphylococcal
agents (1992)25
5. Cephalosporins (1994)15
6. Enumerate pediatric conditions in which Erythromycin is the drug of choice (1997/1)10
7. Mechanism of Drug resistance (1997/1) 15
8. Early detection of Chloramphenicol toxicity (2003/1)15
9. Third generation cephalosporins (2003/1)15
10. Aztreonam (2003/2)15
11. Discuss the basis for development of antibiotic resistance. Outline the steps for prevention of
antibiotic resistance. (2004/2)5+5
12. Management of infections by organisms producing extended spectrum beta lactamase (2006/1)10
13. Principles of rational antibiotic therapy (2017/2) 5
14. Mechanisms of antibiotic resistance (2017/1) 5
15. Mechanisms of antibiotic resistance. (2020/01)5
ANTIFUNGALS
1. Describe the antifungals available for systemic use in India with their dosage, route and duration
of therapy for treatment of
a) systemic candidiasis; and b) Invasive aspergillosis (2009/2)5+5
ANTIVIRAL DRUGS
100
DNBpedia ® 2021
101
DNBpedia ® 2021
VACCINES
VACCINOLOGY
1. Enumerate all the diseases against which vaccines are currently available (1993/2)15
2. Immunization schedule basis in child suffering from AIDS (1994)15
3. Live vaccines used in pediatric age group (1995/1)10
4. Adverse reactions that may occur following use of vaccines included in the National
5. Immunization Schedule in India (1995/2)10
6. Describe briefly various adverse reactions following vaccinations and discuss their management
(1997/2)25
7. Combination vaccine (1999/2)(2003/1)15
8. Vaccine Vial Monitor 15
9. Tabulate the various newer vaccines available to prevent respiratory disease in children, with their
types, dosage schedule, route, important side effects and efficacy. (2011/2)10
10. Salient differences between the National and IAP immunization schedule. (2013/1)(5)
11. Describe the criteria or conditions to be considered for approving a ‘newer’ vaccine in an
12. immunization program of a developing country. (2008/1) (2013/2) 10
13. Define the following: (2013/1)2X5
a. Herd immunity
b. Herd effect
c. Vaccine immunogenicity
d. Vaccine efficacy; and
e. Vaccine effectiveness
14. Cold Chain (2000/1)15, (2014/2)5
15. Conjugate vaccines (2015/1) 3
16. Pentavalent vaccines (2016/2)
17. Adolescent vaccination (2017/1) 5
18. Adolescence immunization (2018/2)5
19. Immunization in immunosuppressed children [2018/1/5]
20. Classification of AEFI (2019/1) 5
21. Components of cold chain for immunisation in a hospital setting and its monitoring (2019/1) 5
22. Combined vaccines (2019/1) 5
23. Different immunisation campaigns in India and their role in improving immunization coverage
(2019/2)6
24. Future vaccines (2019/2) 5
RABIES VACCINE
1. Write briefly about different types of vaccine against rabies. Discuss various schedules of pre and
post-exposure prophylaxis for rabies.(2012/1) 5+5
2. Anti-rabies vaccine – Different schedules, advantages of each schedule (2019/2)5
3. Post exposure prophylaxis for dog bite (2020/01)5
VARICELLA VACCINE
1. Varicella vaccine (2000/1)15
MEASLES VACCINE
1. Complications of measles vaccination and management (1994/2)15
HIB VACCINE
1. H Inuenzae B vaccine (1998/2)15
102
DNBpedia ® 2021
2. Tabulate the following details with regards to Rotavirus vaccine, HIB vaccine and pneumococcal
vaccine: (2009/2)10
a) Type of vaccine
b) Dose
c) Route
d) Appropriate age of vaccination
e) Justification of its usage
f) Side effect and
g) Drawback
TYPHOID VACCINE
1. Typhoid Vaccines (1997/1)15
2. Typhoid vaccines (2019/1) 5
3. Typhoid conjugate vaccine. (2020/01)5
HEPATITIS B VACCINE
1. Hepatitis B immunization (1993/2)10
2. Hepatitis B vaccine (1996/1), (1997/1)10
PNEUMOCOCCAL VACCINE
1. Pneumococcal vaccine (1996/2)15
2. Pneumococcal vaccine (2017/2) 5
INFLUENZA
1. Influenza Type B vaccine (1998/1)15
DPT
1. Current status of post-DPT vaccine encephalopathy (1993/1) 15
2. Discuss the aetiology, pathogenesis and prevention of pertussis in children. Write the differences
in efficacy, duration of protection and adverse effects between whole cell and acellular pertussis
vaccine. (2014/1)6+4
POLIO
1. Status of Polio vaccines (1993/1)15
2. Discuss the current role, advantages and disadvantages of OPV and IPV in control and eradication
of poliomyelitis in India. (2011/1)4+6
3. What is inactivated polio vaccine (IPV). What are the advantages and disadvantages of IPV over
OPV? What is the schedule of IPV as recommended by IAP. (2014/2) 3+5+2
4. VAPP (Vaccine Associated Paralytic Poliomyelitis) 5 (Apr 2016)
HPV
1. Utility and controversy of HPV Vaccine. (2010/1)5+5
2. HPV vaccine (2015/1)4
3. HPV vaccine-current status [2018/2]5
ROTA VIRUS
4. Rota virus vaccine (2015/1) 3
5. Rota virus vaccine- schedule, dosage, side effects (2017/1) 5
103
DNBpedia ® 2021
STATISTICS
1. Define evidence based medicine, as applicable to pediatric practice. Enlist basic steps in the
practice of evidence based medicine. Name few databases of systematic reviews. (2008/1)10
2. Clarify the concept of evidence based medicine. Define ‘strength of evidence ‘and ‘quality of
evidence’. Provide suitable examples to justify your Definitions. (2011/1)3+3+4
3. What is Evidence Based Medicine? How are the guidelines based on Evidence Based Medicine
developed? How are the recommendation graded for the level of evidence? (2011/2)2+4+4
4. Define and describe the following concepts used for measuring growth:
a) Percentile b) Percent of median c) Z scores. Discuss their relation to each other. (2012/1)
2+2+3+3
5. Discuss the following: (2014/1)3+3+4
6. Student’s ‘t’ test
a. Sample size
b. Ethics in research
c. Types of error in research study (2014/2)4
7. Define and explain sensitivity, specificity, positive predictive value and negative predictive value of
a diagnostic test. (2010/2)2.5 X 4(2014/2) 2+2+2
8. a) Component of ethics in biomedical research 4
b) “p value” and its level of significance 3
c) Association concealment 3(2015/1)
9. a) What is bias in medical research 2
b) Common types of bias and the methods to minimize bias in analytic studies 4+4 (2015/2)
10. a) What is relative risk (RR) and discuss its implications.? 1+3
b) What is usefulness of confidence interval? 3
11. Implications of sensitivity and specificity. 3(2015/2)
12. Measures of Central tendency (2018/1/5), (2016/2)5
13. Evidence based medicine 6
Forest plot in meta analysis 4 (Apr 2016)
14. Clinical trials phase 1, phase 2, phase 3 and phase 4.
Ethics in biomedical research 5+5(Apr 2016)
15. Forest plot graph 3 (01/2016)
16. Meta-analysis 3 (01/2016)
17. Ethical principles when doing research on humans (2018/1/5)
18. Study designs (2018)
19. Components of structured abstract (2018/1) 4
20. Characteristics of a good research question (2017/2) 4
21. Need and methods of blinding for research (2017/2) 6
22. Observational studies (2017/1) 4
23. Metanalysis (2017/1) 4
24. Assessing the value of diagnostic test (2017/1) 3
25. Odds ratio (2016/2) 5
26. Steps in planning a RCT (2019/1) 5
27. Source of health information in research (2018/2) 5
28. Tests of statistical significance (2018/2) 5
29. Comment critically on “Evaluation of a diagnostic test study” (2019/2)6
104
DNBpedia ® 2021
105
DNBpedia ® 2021
MISCELLANEOUS TOPICS
1. Value of USG in pediatrics (1993/1)10
2. Role of Upper GI Endoscopy (1993/1)15
3. Respiratory system defence mechanisms (1993/2)15
4. Pathogenesis of oedema (1995/1)15
5. Food Fussiness in children (1995/1)10
6. Effect of Television watching in children (1995/1)15
7. Indications for various organ and tissue transplants in Pediatric practice and common
considerations in selection of donors (1995/2)10
8. Differential diagnosis of Hemoptysis in children (1995/2)10
9. Tetany in children (1996/1)12
10. Cardiovascular Risk factors in children (1996/1)15
11. Primary Endocardial Fibroelastosis (1998/1)15
12. Role of oxygen free radicals in the causation of childhood diseases (1997/1)15
13. CPAP (2006)10
14. Role of Pediatrician in Disaster management (2006/1)10
15. Write short notes on: Female infanticide (2009/2) 5
16. Tips on parental guidance for computer and internet usage by children (2013/1)(5)
17. Free radicals 5(2015/2)
18. Role of O2 free radicals in the pathogenesis of neonatal disorders (1996/2)10
19. Biology and role of cytokines in Newborn Infants (2006/1)10
20. ECMO (2006/1)10
21. Discuss the proposed hypothesis on ‘fetal origins of adult disease ‘and its implications on burden
of diseases. (2011/1)5+5
22. Neonatal hemochromatosis (2015/1)5 19.
23. Biology and role of cytokines in newborn infants (1/2016)3
24. Steps to curb female infanticide. 5 (01/2016)
25. Simulation- newer medical teaching training technology (2019/1) 5
26. Techniques of bone marrow aspiration and its indications (2019/1) 5
27. Plasmapheresis (2018/2) 5
28. Immunotherapy (2019/2)5
29. Emerging infections (2019/2)5
30. Role of USG in NICU (2019/2)5
31. Nipah infection: Symptoms and prevention (2019/2)5
32. PET Scan – Indications and risks (2019/2)4
33. Rational Oxygen Therapy (2019/2)5
34. FOAD (Fetal origin of adult disease) 5(2019/2)
35. Intraosseous infusions: Indications and complications. (2020/01)5
36. Cytokine storm. (2020/01)5
37. Discuss the ill-effects of digital media on child health and the Guidelines for their prevention.
(2020/01)5+5
38. Teleconsultation Guidelines, Advantages and Drawbacks. (2020/01)5
39. Umbilical Cord Blood Banking: Pros and Cons. (2020/01)5
40. IAP Guidelines on junk food, and fruit juices. (2020/01)5
106
DNBpedia ® 2021
www.DNBpedia.com
AN ACADEMIC PLATFORM FOR DNB PEDIATRICS RESIDENTS
Follow us at: Facebook.com/DNBpedia
2nd Edition
January 2021
107